You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博濟醫藥(300404.SZ)擬定增募資不超3.43億元 用於合同研發生產組織(CDMO)平台建設項目等
格隆匯 03-09 18:41

格隆匯3月9日丨博濟醫藥(300404.SZ)披露2020年度創業板非公開發行A股股票預案,此次非公開發行募集資金總額(含發行費用)不超過約3.43億元(含該數),扣除發行費用後的募集資金淨額將用於投資以下項目:1.07億元用於合同研發生產組織(CDMO)平台建設項目;8463.34萬元用於創新藥研發服務平台建設項目;4879.28萬元用於臨牀研究服務網絡擴建與能力提升項目;約1.03億元用於補充流動資金。

此次非公開發行股票的發行對象為不超過35名(含35名)符合中國證監會規定條件的特定對象,包括符合規定條件的證券投資基金管理公司、證券公司、信託投資公司、財務公司、保險機構投資者、合格境外機構投資者,以及符合中國證監會規定的其他法人、自然人或其他合格的投資者。其中,證券投資基金管理公司、證券公司、合格境外機構投資者、人民幣合格境外機構投資者以其管理的2只以上產品認購的,視為一個發行對象;信託投資公司作為發行對象的,只能以自有資金認購。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account